Skip Navigation


CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable podcast. CIT can also broadcast NIH-only or HHS-only content.

Genetic Therapies for Genetic Diseases: Results and Lessons from Recent Successes

Loading video...

306 Views  
   
Air date: Wednesday, May 29, 2013, 3:00:00 PM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 306, (130 Live, 176 On-demand)
Category: WALS - Wednesday Afternoon Lectures
Runtime: 00:58:01
Description: Wednesday Afternoon Lecture Series

The disease burden represented by genetic disease is high. Genetic diseases account for nearly half of all admissions to children’s hospitals, yet therapeutic options for many of these are limited. The goal of gene therapy is to harness the power of the Human Genome Project to provide better alternatives for those with genetic diseases. After two decades of clinical investigation of gene therapy, the field is able to point to several successes and one licensed product (an AAV vector for lipoprotein lipase deficiency). This lecture will review the vectors that have performed best in the setting of genetic disease and will focus on genetic diseases for which promising results have been reported using AAV vectors, including hemophilia B and Leber’s congenital amaurosis, a rare form of inherited retinal degeneration. Delineation of major obstacles to clinical success will be reviewed and solutions discussed. Finally, in more recent work, it has been possible to combine genome editing approaches with AAV-mediated gene transfer to effect correction of mutations in situ. Strategies for using this approach to correct both plasma protein deficiencies and lysosomal storage disorders will be reviewed.
Debug: Show Debug
NLM Title: Genetic therapies for genetic diseases : results and lessons from recent successes / Katherine A. High.
Series: Wednesday afternoon lecture series
Author: High, Katherine A.
National Institutes of Health (U.S.),
Publisher:
Other Title(s): Wednesday afternoon lecture series
Abstract: (CIT): The disease burden represented by genetic disease is high. Genetic diseases account for nearly half of all admissions to children's hospitals, yet therapeutic options for many of these are limited. The goal of gene therapy is to harness the power of the Human Genome Project to provide better alternatives for those with genetic diseases. After two decades of clinical investigation of gene therapy, the field is able to point to several successes and one licensed product (an AAV vector for lipoprotein lipase deficiency). This lecture will review the vectors that have performed best in the setting of genetic disease and will focus on genetic diseases for which promising results have been reported using AAV vectors, including hemophilia B and Leber's congenital amaurosis, a rare form of inherited retinal degeneration. Delineation of major obstacles to clinical success will be reviewed and solutions discussed. Finally, in more recent work, it has been possible to combine genome editing approaches with AAV-mediated gene transfer to effect correction of mutations in situ. Strategies for using this approach to correct both plasma protein deficiencies and lysosomal storage disorders will be reviewed.
Subjects: Genetic Diseases, Inborn--genetics
Genetic Diseases, Inborn--therapy
Genetic Therapy--methods
Publication Types: Lectures
Webcasts
Download: To download this event, select one of the available bitrates:
[64k]  [150k]  [240k]  [440k]  [740k]  [1040k]    How to download a Videocast
Caption Text: Download Caption File
NLM Classification: QZ 50
NLM ID: 101611635
CIT Live ID: 12334
Permanent link: http://videocast.nih.gov/launch.asp?17974